Nationwide Study on Practices Related to Screening Among Greek Paediatricians

Christos Dresios1, Georgios Rachiotis1, Xanthi Rousou1

  • 1Department of Hygiene and Epidemiology, University of Thessaly School of Medicine, Larissa, Greece.

Insights

Greek pediatricians show significant gaps and variability in screening practices, particularly those with less experience or higher patient loads. Development of a national childhood screening program is recommended.

Area of Science:

  • Pediatrics
  • Public Health
  • Health Services Research

Background:

  • Screening practices are crucial for early detection of childhood diseases.
  • Variability in adherence to guidelines can impact patient outcomes.
  • Understanding current practices among healthcare providers is essential for targeted interventions.

Purpose of the Study:

  • To evaluate the current screening practices of pediatricians in Greece.
  • To identify factors associated with suboptimal screening adherence.
  • To inform the development of a national screening program.

Main Methods:

  • A nationwide survey of 371 pediatricians in Greece.
  • Data collected via a pilot-tested questionnaire.
  • Statistical analysis included multivariable logistic regression and latent class analysis.

Main Results:

  • A response rate of 78.6% (294 participants).
  • Pediatricians with <15 years of experience, age >50, or >80 patients/week showed higher non-compliance.
  • Female gender, age <50, and private sector work correlated with poorer adherence to international guidelines.

Conclusions:

  • Significant gaps and variability exist in Greek pediatricians' screening practices.
  • Experience, age, patient volume, and practice setting influence adherence.
  • A national childhood screening program is needed in Greece to standardize care.
Abstract

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.5K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
126
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
94
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
144